Penn Medicine was selected for this focused outreach initiative because of the way Penn is redefining where complex care can be delivered. Your home infusion model combines the clinical standards of an academic health system with the convenience and personalization of care at home, while programs such as Cancer Care at Home show how carefully selected therapies can move safely beyond traditional settings. Penn’s focus on delivering the right care in the right place, supporting patients after discharge and helping them thrive at home creates a differentiated model built around access, continuity and the patient experience. Prochant can help strengthen that model by bringing greater consistency, visibility and intelligence to the revenue cycle processes that support timely access to home-based therapy. effective alternative to inpatient care. Prochant can reinforce those differentiators by bringing the same coordination, reliability and focus on outcomes to the revenue cycle supporting infusion care.Prochant can reinforce those priorities by bringing the same coordination, responsiveness and focus on outcomes to the revenue cycle supporting infusion care.
That model also brings significant operational complexity. As home infusion programs expand across therapies, locations and patient populations, health systems need a coordinated revenue cycle that keeps every stage aligned, prevents handoff gaps and supports consistent reimbursement without delaying care. Payer variation, increasingly complex drug reimbursement and disconnected workflows can create denials, rework and limited visibility, making it difficult for revenue cycle operations to keep pace with clinical innovation and growth.
At Prochant, we partner with health systems facing similar challenges across their home infusion services. We bring greater visibility, automation and discipline to the revenue cycle by combining specialized home infusion expertise, AI-enabled technology and proven processes. This approach helps identify reimbursement risks earlier, reduce denials, improve financial performance and support scalable growth without compromising access, safety or the patient experience.
Why You Should
Choose Prochant
Accelerate the Path from Referral to Home Treatment
Use Prochant’s specialized home infusion intake services and AI-driven technology to streamline benefits verification, prior authorization and documentation review. This can reinforce Penn’s “easy referrals” model and its commitment to coordinating insurance coverage before care begins, helping patients start therapy without avoidable administrative delays.
Create Therapy-Level Financial Visibility
Give Penn Medicine at Home leadership actionable insight into authorizations, claims, denials, A/R and payer performance across complex therapies. This makes it easier to identify reimbursement risk by therapy, payer or workflow before it affects treatment access or medication delivery.
Build RCM Processes That Match Penn’s High-Reliability Model
Apply the standardized, measurable Prochant Process across intake, billing and collections, as Penn expands care beyond traditional settings. A more disciplined revenue cycle can complement Penn’s use of proven processes, rigorous safety standards and continuous performance improvement across thousands of home infusion patients.
Make Innovative Home-Based Therapies Financially Sustainable
Improve claim accuracy, reduce denials and accelerate collections through payer-specific expertise, AI-driven insights and focused A/R follow-up. Stronger reimbursement performance can help Penn continue scaling models that reduce unnecessary facility visits, preserve patients’ independence and deliver complex care in the setting that best fits their lives.
Success Story
Revenue Cycle Results for a Health System
A leading academic medical center faced revenue cycle delays across its home infusion services due to manual cash posting, paper-based remittances and intake staffing gaps.
Prochant helped automate remittance workflows, improve cash posting accuracy, strengthen reporting visibility and create a more structured process for ongoing KPI review and workflow optimization.
Within six months, the organization achieved:
- 18% reduction in A/R over 90
- 21% decrease in DSO
- 14% growth in its infusion business
Recommended Resources
How Health Systems Can Build a Stronger Home-Based Care RCM Strategy
Top 3 Revenue Cycle Challenges for Health Systems in Infusion
Join Our Upcoming NHIA Webinar
“The Revenue You Never See: Finding Leakage Across the Infusion Lifecycle”
Not all lost revenue appears as a denial. In many cases, revenue is lost before a claim is ever submitted through missed charges, incomplete documentation, authorization mismatches, incorrect billing units, payer configuration errors or underpayments that go unnoticed. This session would introduce a broader approach to revenue integrity in home infusion by tracing revenue from referral through final payment. Attendees would examine how clinical, operational and financial workflows intersect and where breakdowns can quietly reduce reimbursement. The discussion would focus on identifying leakage points that traditional collections reporting may not reveal and building controls that prevent revenue loss rather than simply reacting to it later. The session would also explore how billing, operations, intake and contracting teams can work together to create stronger accountability around earned revenue.
Special Offer for
To support this partnership discussion, Prochant will waive implementation fees for new engagements initiated by Penn Medicine.
This allows your team to evaluate opportunities for operational improvement and revenue cycle optimization with reduced upfront investment.
You work hard to earn your revenue.
Count on us to bring it home.
© 2026 Prochant. All rights reserved.